Literature DB >> 19551824

Human T-lymphotropic virus type 1 (HTLV-1) genetic typing in Kakeroma Island, an island at the crossroads of the ryukyuans and Wajin in Japan, providing further insights into the origin of the virus in Japan.

Katsuyuki Eguchi1, Hidefumi Fujii, Kengo Oshima, Masashi Otani, Toshiaki Matsuo, Taro Yamamoto.   

Abstract

Peripheral blood samples were collected from 23 human T-lymphotropic virus type-1 (HTLV-1) carriers residing in Kakeroma Island, Japan (Kagoshima Prefecture, Oshima County, Setouchi Town), one of the most highly endemic areas in Japan. The samples were subjected to amplification by PCR and sequencing of the Long Terminal Repeat in order to reconstruct a phylogenetic tree of HTLV-1 isolates. Restriction Fragment Length Polymorphism (RFLP) analysis of env region was also conducted for subgrouping of HTLV-1. Although one sample could not be amplified by PCR, and three more could not be sequenced due to the existence of conspicuous nonspecific bands or repeated sequences, the phylogenetic analysis revealed that the remaining 19 isolates obtained from Kakeroma Island belonged to either the Transcontinental or the Japanese subgroups of the Cosmopolitan subtype, one of the three major subtypes. The RFLP data corresponded closely with the typing data throughout the sequencing. The proportion of the Transcontinental subgroup among the isolates was 26.3% (5 of 19) by sequence analysis and 27.3% (6 of 22) by RFLP. Unlike in Taiwan, China and Okinawa, the Japanese subgroup was dominant in Kakeroma Island. The analysis would also suggest that the Japanese subgroup seems not to have derived from the Transcontinental subgroup, but rather that the Transcontinental subgroup came to Japan first and was followed later by the Japanese one. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19551824     DOI: 10.1002/jmv.21540

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  An overview of sequencing technology platforms applied to HTLV-1 studies: a systematic review.

Authors:  Felipe de Oliveira Andrade; Marina Silveira Cucco; Melina Mosquera Navarro Borba; Reinaldo Conceição Neto; Luana Leandro Gois; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Fernanda Khouri Barreto
Journal:  Arch Virol       Date:  2021-08-20       Impact factor: 2.574

2.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

3.  Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to Japan.

Authors:  Masashi Otani; Katsuyuki Eguchi; Tatsuki Ichikawa; Kohei Takenaka Takano; Toshiki Watanabe; Kazunari Yamaguchi; Kazuhiko Nakao; Taro Yamamoto
Journal:  Trop Med Health       Date:  2013-01-19

4.  The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.

Authors:  Jinzhen Xie; Shengxiang Ge; Yali Zhang; Yongcai Lin; Hongying Ni; Jun Zhang; Changrong Chen
Journal:  PLoS Negl Trop Dis       Date:  2015-04-01

Review 5.  Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.

Authors:  Philippe V Afonso; Olivier Cassar; Antoine Gessain
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

6.  Prevalence and evolutionary analyses of human T-cell lymphotropic virus in Guangdong province, China: Transcontinental and Japanese subtype lineages dominate the prevalence.

Authors:  Qiao Liao; Zhengang Shan; Min Wang; Jieting Huang; Ru Xu; Tingting Li; Wenjing Wang; Chengyao Li; Xia Rong; Yongshui Fu
Journal:  PLoS Negl Trop Dis       Date:  2021-02-04

7.  Distribution of Two Subgroups of Human T-Lymphotropic Virus Type 1 (HTLV-1) in Endemic Japan.

Authors:  Masashi Otani; Noritaka Honda; Pin-Cang Xia; Katsuyuki Eguchi; Tatsuki Ichikawa; Toshiki Watanabe; Kazunari Yamaguchi; Kazuhiko Nakao; Taro Yamamoto
Journal:  Trop Med Health       Date:  2012-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.